Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

Clinical trial NCT06843239 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06843239
Sponsor: Zura Bio Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Sclerosis (SSc)Scleroderma

Start date: 2025-02-06
Primary completion: 2027-05-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.